Posters

Clinical characteristics and visual outcomes of anterior segment intraocular foreign bodies

Poster Details

First Author: M.Stamenkovic SERBIA

Co Author(s):    V. Lukic   I. Sencanic   V. Jaksic   M. Mavija   R. Gvozdenovic   A. Radosavljevic              

Abstract Details



Purpose:

To investigate epidemiologic, clinical characteristics and visual outcomes of posttraumatic intraocular foreign body (IOFB)

Setting:

Eye Clinic, Zvezdara Medical University centre, Belgrade, Serbia

Methods:

Consecutive series of 19 eyes with IOFB located in anterior segment presented at the Eye Clinic, Zvezdara Medical University centre from 2010 to 2014. Data on the history of injury, preoperative status of the eye, and management of injuries were collected retrospectively. If data were not available, the patient was excluded from analysis for that particular data point. Slit lamp examination was carried out on all eyes without the use of a contact lens. Best corrected visual acuity (BCVA) was determined with the Snellen E chart. The site of the wound in the globe wall, the number, material, location all were recorded if known

Results:

The average patient age was 29.53 years with mail predominance (17 male patients, and 2 female). There were n=7 (36.84%) right eyes and n=12 (63.16%) left eyes involved. The most frequent injury mechanism was hammering n=8 (42.11%), and the composition of IOFB was metallic in 13 cases (68.42%). Initial VA was • Less 0.1 n=11 eyes (57.89%) • 0.1-0.4 n=2 eyes (10.53%) • 0.5 and more n=5 eyes (26.32%) Final BCVA: • Less 0.1 n=5 (26.32%) eyes • 0.1-0.4 n=3 (15.79%) eyes • 0,5 and more n=5 (26.32%) eyes • No data n=6 patients Complications • Endophthalmitis n=2 eyes(10.53%) • Cataract n=7 eyes (36.84 %) • Vitreous haemorrhage n=2 eyes (10.53%) • Hyphaema n=1 eyes (5.26%)

Conclusions:

Initial VA generally is one of the most important prognostic factors for predicting final visual outcome after IOFB injuries. Other factors that predict poor final vision are large wound size and the development of complications, particularly endophthalmitis.

Back to previous
EURETINA, Temple House, Temple Road, Blackrock, Co Dublin. | Phone: 00353 1 2100092 | Fax: 00353 1 2091112 | Email: euretina@euretina.org

Privacy policyHotel Terms and Conditions Cancellation policy